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Background: Streptococcus pneumoniae (the pneumococcus) is the world’s foremost microbial pathogen, killing
more people each year than HIV, TB or malaria. The capacity to penetrate deeper host tissues contributes substantially
to the ability of this organism to cause disease. Here we investigated, for the first time, functional genomics
modulation of 3 pneumococcal strains (serotype 2 [D39], serotype 4 [WCH43] and serotype 6A [WCH16]) during
transition from the nasopharynx to lungs to blood and to brain of mice at both promoter and domain activation
levels.
Results: We found 7 highly activated transcription factors (TFs) [argR, codY, hup, rpoD, rr02, scrR and smrC] capable of
binding to a large number of up-regulated genes, potentially constituting the regulatory backbone of pneumococcal
pathogenesis. Strain D39 showed a distinct profile in employing a large number of TFs during blood infection.
Interestingly, the same highly activated TFs used by D39 in blood are also used by WCH16 and WCH43 during
brain infection. This indicates that different pneumococcal strains might activate a similar set of TFs and regulatory
elements depending on the final site of infection. Hierarchical clustering analysis showed that all the highly activated
TFs, except rpoD, clustered together with a high level of similarity in all 3 strains, which might suggest redundancy in
the regulatory roles of these TFs during infection. Discriminant function analysis of the TFs in various niches highlights
differential regulatory backgrounds of the 3 strains, and pathogenesis data confirms codY as the most significant
predictor discriminating between these strains in various niches, particularly in the blood. Moreover, the predicted TF
and domain activation profiles of the 3 strains correspond with their distinct pathogenicity characteristics.
Conclusions: Our findings suggest that the pneumococcus changes the short binding sites in the promoter regions of
genes in a niche-specific manner to enhance its ability to disseminate from one host niche to another. This study
provides a framework for an improved understanding of the dynamics of pneumococcal pathogenesis, and opens
a new avenue into similar investigations in other pathogenic bacteria.Background
Streptococcus pneumoniae (the pneumococcus) continues
to cause high morbidity and mortality worldwide, in spite
of the availability of vaccines and antimicrobial therapies
[1,2]. Resistance of virulent S. pneumoniae to multiple
antibiotics, particularly against beta-lactams is due to
alterations in the structure of six penicillin-binding* Correspondence: david.ogunniyi@adelaide.edu.au
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unless otherwise stated.proteins, while macrolide resistance is mediated through
the erm(B), mefA or mefE genes [3]. This could partly be
explained by the fact that the organism deploys an effi-
cient virulence machinery during infection. Consequently,
research efforts have been geared towards understanding
the molecular mechanisms underlying the pathogenesis of
pneumococcal disease [4-6]. However, due to technical
difficulties associated with harvesting RNA for analysis of
in vivo transcription patterns of pneumococci during
pathogenesis, most studies have either studied the earlier
stages of infection (nasopharynx and lungs) or used in vitro
surrogates [7-10]. Recently, these challenges have beenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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parisons of differentially-regulated genes during penetration
of deeper host tissues [11-13].
Notwithstanding these significant advances, progress
on a comprehensive understanding of the dynamics of
pneumococcal pathogenesis is still hampered by paucity
of data on different levels of functional genomics (such as
promoter activation and domain interaction), particularly
for pneumococci with distinct pathogenicity character-
istics. It is known that gene function is the outcome of
harmony between the upstream non-coding promoter re-
gion and the downstream coding sequence [14] (Figure 1).
Despite the prominent role of transcription factors (TFs)
in controlling the expression of many genes [15,16], their
impact on pathogenesis of pneumococcal disease has not
been studied in detail, probably due to their transient, and
generally low expression levels. A study of 60 bacterial
genomes showed that larger genomes harbour more TFs
per gene than smaller ones [17]. This suggests that under
complex conditions, gene expression, regulation and signal
integration have been strongly selected to enable rapid
adaptation to environmental conditions, triggering emer-
gence of new strains. A differential fluorescence inductionFigure 1 Different layers of functional genomics and organism fitness
region and downstream coding sequence leading to gene function.study showed that pneumococcal surface antigen (psa)
promoter, which drives expression of the psaBCA op-
eron involved in manganese uptake and virulence in S.
pneumoniae [18,19] is markedly activated during lung
infection [20]. Recently, we found a novel transcriptional
regulatory circuit consisting of two TFs (SmrC [SP_0927]
and SP_0676) plays a significant role in pathogenesis and
virulence of S. pneumoniae [21]. However, to date, there is
no report that provides a detailed characterization of TFs
(and their corresponding regulatory elements) and their
activation patterns during pneumococcal translocation
from the nasopharynx to deeper host tissues. The usual
approach to address this problem involves the use of in
silico analysis of promoter regions of differentially regulated
genes and prediction of involved TFs, using the whole gen-
omic sequence of a particular strain based on orthology
[22-24]. Given the fact that functional specificity of proteins
is conserved among orthologs [25], it is possible to com-
pare whole genomes of S. pneumoniae with Escherichia coli
to gain information on the TF and promoter activation
map of pneumococcal virulence machinery.
The study of activated domains of expressed proteins
in addition to promoter activation profiles can result in, showing integration between upstream non-coding promoter
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to TFs, more information is available on pneumococcal
pathogenesis at the level of expressed protein domains
because of its use in vaccine design. The role of ATP-
dependent transport and DNA binding domains in
pneumococcal competence [26], histidine kinase in sens-
ing environmental cues and virulence [27], and the role of
PsaA in virulence [18,28], are well documented. Genome
wide analysis of histidine kinases and response regulators
has led to the discovery of new response regulator loci
[27], while mutation in the DNA gyrase domain has
resulted in resistance to quinolones [29].
In the present study, we used functional genomics tools
to examine the underlying molecular mechanisms that
underpin the different pathogenicity characteristics of 3
pneumococcal strains at both promoter (transcriptomic)
and domain (proteomic) activation levels. To our know-
ledge, this combined approach of characterizing in vivo
microarray data has not been reported previously and can
be used as a model for unraveling functional genomics
attributes of other pathogenic bacteria.
Results
For the purposes of this investigation, we have used 3
well-characterised pneumococcal strains: D39 (serotype 2),
WCH43 (serotype 4) and WCH16 (serotype 6A). Mouse
intranasal challenge experiments have shown that D39 and
WCH43 are more virulent than WCH16. However, D39
causes severe pneumonia and high-grade bacteremia, while
WCH16 and WCH43 have a propensity to translocate to
the brain of infected mice [21,30] (see Additional file 1:
Figure S1). Nevertheless, WCH43 infection of mice
demonstrates the “classical” disease progression from
the nasopharynx to the lungs and dissemination to
blood and then to the brain while WCH16 seems to
progress directly to the brain with minimal lung and
blood involvement [21,31]. These striking differences in the
pathogenicity and virulence characteristics of these strains
make them ideal for comprehensive functional genomics
analyses.
Pneumococcal strains activate a variety of TFs during
pathogenesis
Our initial bioinformatic analysis of microarray data for
D39, WCH16 and WCH43 at 72 h post-infection of mice
suggests that WCH16 up-regulates many genes in the
lungs and brain, WCH43 up-regulates many genes in the
brain, whereas D39 has significant genome activation in
the blood. The list of up-regulated genes of D39, WCH16
and WCH43 during pathogenesis is presented in Additional
files 2, 3, 4: Tables S1-S3.
We then characterized pneumococcal TFs capable of
binding to a variety of up-regulated genes during patho-
genesis and compared their activation profiles betweenD39, WCH16 and WCH43. Generally, the highest differ-
ential TF activation profile could be observed in the
blood (see Additional file 5: Table S4). For D39, a total
of 2196 transcription factor-binding sites (TFBs) or
regulatory elements were found, while this number
dramatically fell to 69 for WCH43 and just 11 for
WCH16 in the blood. In this niche, TFs with the highest
number (at least 100) of TFBs (such as argR, codY, hup,
rpoD, rr02, scrR and smrC) were found in D39 (Table 1).
The potential TFBs for each of the TFs are listed in
Additional file 6: Table S5. The most active TF for all 3
strains in the blood was rpoD, although its activation
rate is markedly different between the strains (3 predicted
binding sites in WCH16, 26 in WCH43, and 767 in D39).
Interestingly, a very high number of TFBs were associated
with all these TFs (particularly rpoD, hup and rr02) in
WCH16 and WCH43 during brain infection. We also
compared activated TFs between D39, WCH16 and
WCH43 during transition from the nasopharynx to the
lungs. This revealed the same 7 activated TFs for WCH16
and WCH43, while 5 were activated for D39. Of these,
rpoD was the most active TF for all 3 strains, with 74, 23
and 17 binding sites on the promoter regions of up-
regulated genes in WCH16, WCH43 and D39, respect-
ively (Table 1).
Activated TFs with the highest number of TFBs cluster
together
We sought to determine if there are any relationships or
commonality between the activated TFs that we identified
above in the 3 strains regarding their binding potential to
the promoter regions of up-regulated genes during infec-
tion by hierarchical clustering analysis. Interestingly, we
found that all activated TFs harbouring the highest num-
ber of TFBs (argR, codY, hup, rr02, scrR and smrC), except
rpoD, clustered together with a high level of similarity
(>70%) in all 3 strains (Figure 2, A-D). These results were
further validated by clValid [32], using internal and stabil-
ity cluster validation measures to design a threshold line
to generate 2 clusters. The threshold line shows that rpoD
has a distinct differential activation profile compared to the
other TFs (Figure 2, A-D; see Additional file 7: Table S6).
We also compared the clustering profiles of all activated
TFs across niches between the 3 strains. This showed that
TFs that regulate the transition of WCH16 and WCH43
from the blood to the brain clustered together, with a very
high level of similarity. Moreover, the TFs that regulate
translocation from the nasopharynx to the lungs clustered
with those activated during transition from the blood to
brain for both strains, albeit at a lower level (Figure 3).
We also found that TFs that control transition from
the nasopharynx to the lungs for D39, and those
responsible for transition from the lungs to blood for
WCH43 clustered together, while the TFs that regulated
Table 1 Transcription factors (TFs) with the highest number of binding sites on the promoter regions of up-regulated
genes during pneumococcal pathogenesis
TF Lungs vs nasopharynx Blood vs lungs Brain vs blood
WCH16 WCH43 D39 WCH16 WCH43 D39 WCH16 WCH43
SP_0927 (smrC) 13 4 3 115 18 18
SP_1073 (rpoD) 74 23 17 3 26 767 94 113
SP_1113 (hup) 26 10 4 2 4 249 36 39
SP_1227 (rr02) 20 4 6 1 6 137 31 31
SP_1584 (codY) 19 3 8 175 28 25
SP_1725 (scrR) 16 4 1 1 72 15 17
SP_2077 (argR) 14 7 1 4 7 201 17 23
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These clustering patterns were also validated by c1Valid,
and based on the 2 generated clusters after applying
threshold line, blood vs lungs in strain D39 shows a
distinct profile of activated TFs (Figure 3, Additional
file 7: Table S6). These differences in TF activation
profiles across niches are consistent with the biolumines-
cence patterns of the 3 strains in mice (Additional file 1:
Figure S1).Figure 2 Comparative transcription factor activation patterns in diffe
(A), WCH16; (B), WCH43; (C), D39, and (D) for the 3 strains.Activated TFs exhibit different behavior between
pneumococcal strains
We used discriminant function analysis to compare the
relative impact (weight) of TFs between the 3 strains in
various niches. Comparison of D39 and WCH16 showed
that both strains have relatively similar discriminant
models in the lungs. In the blood, a large number of TFs
have opposite signs between D39 and WCH16. This high-
lights differential regulatory backgrounds of both strainsrent S. pneumoniae strains. Dendogram shows TF activation map for
Figure 3 Clustering profiles of activated transcription factors of S. pneumoniae strains across niches.
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discriminant modelling algorithm indicate that D39 and
WCH43 have similar regulatory backgrounds in the lungs
but are different in the blood. The discriminant models of
WCH16 and WCH43 in the lungs and brain show that the
activated TFs have similar coefficient values and signs in
both strains (Additional file 8: Table S7). Interestingly, these
strains choose different models during progression from
lungs to blood. In this instance, of the 7 highly activated
TFs, codY was the most significant predictor discriminating
WCH16 from WCH43 in the blood, where its coefficient
was −38 in WCH16, compared to +13 in WCH43.
Given the predicted discriminant function for codY
between these 3 strains, we hypothesized that a mutant
of codY will show distinct pathogenic profiles between
these strains in vivo. However, we noted that a previous
manuscript reported that codY inactivation in D39 is
difficult due to its essentiality [33] and suggested further
work in other clinical strains to establish if this is a gen-
eral feature of pneumococci. Therefore, we attempted to
delete codY in D39, WCH16 and WCH43 by targeted
mutagenesis using the overlap extension strategy, as
described in Methods. Surprisingly, we obtained putative
mutants in all 3 strains, which were verified to be correctby PCR and sequencing using primers flanking the codY
ORF. We examined if the putative codY mutants carried
the permissive amino acid (Q166→ Stop) mutation in FatC
(SP_1870) and/or amino acids (D480→ Y; D487→ Y) and
amino acids 1–81 deletion mutations in AmiC (SP_1890)
reported previously [33]. This was carried out by PCR and
sequencing of the amiC and fatC genes of 2 independent
mutants from each of the 3 strains. However, we could
not detect any of these reported changes. Next, we tested
the fitness of each of these putative codY mutants in an
in vitro competition with the isogenic wild type over
4.5 hrs. Surprisingly, we found that the mutant of all
3 strains was completely out-competed by the wild
type. Output ratios were 1:1300, 1:655 and 1:1900, for
D39ΔcodY, WCH16ΔcodY and WCH43ΔcodY mutants,
respectively at 3 h. We concluded that while the codY
mutation might have been tolerated in these strains, the
mutation is unstable, in agreement with the finding of
Caymaris and colleagues regarding the essentiality of
CodY [33]. We also found that during in vitro growth,
the antibiotic resistance selection marker in the codY
mutant strains is lost in the absence of selection. This
was verified by replica-plating cells grown on antibiotic
plates onto plates with or without antibiotic; the
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WCH16ΔcodY (1:6.5), compared to 1:5, and 1:1.4, for
the WCH43ΔcodY and D39ΔcodY putative mutants,
respectively.
As a consequence of these findings, we explored an
alternative approach to investigating the discriminant
function of CodY in the 3 strains. We placed codY under
the expression of ami promoter and transformed this
into the 3 strains, generating D39[codY]ind, WCH16
[codY]ind, and D39[codY]ind, respectively. Next, we tested
the fitness of these codYind strains in an in vitro competi-
tion experiment with their otherwise isogenic wild-type
derivatives over 4.5 hrs. In this model, there was no differ-
ence in bacterial counts of the codYind strains compared
to their isogenic wild-type counterparts at any of the time
points tested (not shown). We then investigated the effect
of over-expressing CodY on the in vivo fitness of the
codYind strains relative to their respective wild type coun-
terparts in a mouse intranasal (i.n.) competition experi-
ment over a 36 h period, as described in Methods. Our
analysis shows that there was no significant difference in
the ability of the D39[codY]ind strain to colonise the
nasopharynx or invade the lungs, blood or brain
(Figure 4A). However, the WCH16[codY]ind strain was
massively out-competed by its wild-type counterpart in
all these niches (Figure 4B). Interestingly, the WCH43
[codY]ind strain was only out-competed by the isogenic
wild-type strain in its ability to invade the bloodstream
and brain (Figure 4C). Together, these analyses confirm
the bioinformatics prediction of the discriminant function
of CodY in WCH16, consistent with its role in controlling
the expression of many genes involved in pneumococcal
metabolism and virulence [33,34].
Up-regulated genes are predicted to be co-regulated by
similar sets of TFs in various niches
We then attempted to identify genes (with at least 4 TFBs
in their promoter regions) that are co-regulated by the
same 7 highly activated TFs in the lungs, blood or brain.
This allowed us to construct a series of TF activation
networks for the 3 strains (Figure 5, A-H; see Additional
file 9: Table S8). Overall, our results show that the same
groups of genes were co-regulated by similar sets of TFs
in the lungs and brains of mice infected with WCH16,
and in the brains of mice infected with WCH43. These
results correlate with the TF activation profiles observed
for these strains in those niches (as shown in Figure 3).
Interestingly, only SP_1647 (a metallo-endopeptidase; in
the lungs of D39-infected mice), and SP_1058 (hypothet-
ical protein; in the blood of WCH16-infected mice) were
found to be potentially co-regulated by argR, hup, rpoD
and rr02. We also observed that D39 showed a distinct set
and high number of up-regulated genes in the blood. The
majority of these genes are co-regulated by 4 TFs, exceptfor a set of genes involved in the pentose phosphate
pathway (SP_0316-SP_0320) that are co-regulated by all
but one (smrC) of the 7 highly activated TFs (Figure 5H;
Additional file 9: Table S8). A view of the genome maps
of sequenced S. pneumoniae strains suggests these genes
are grouped in transcriptional units, although the se-
quence of SP_0316 is very short (108 bp) and is absent in
most of these strains (except S. pneumoniae TIGR4 and S.
pneumoniae TCH8431/19A). Search for orthologous
genes and clustering analysis also shows a high level of
identity and conservation for SP_0317-SP_0320 in other
streptococci (such as S. agalactiae, S. faecalis, S. faecium
and S. pyogenes) and in Bacillus subtilis. These results are
reminiscent of redundancy of TF–TFB interactions as de-
scribed for overlapping regulons like SoxS, MarA and Rob
of E. coli [35], and among PrfA/CtsR/HrcA and alternative
sigma factors (σB, σC, σH, and σL) of Listeria monocyto-
genes [36] and among the ςX and ςW regulon in B. subtilis
[37] in which different sites are able to recruit the same
TF, while different TFs can recognize similar sites.
Our analysis also included the identification of genes
that are commonly up-regulated by each of the 7 highly
activated TFs in the lungs, blood or brain for the 3
strains. We restricted our analysis to include the genes
that harbor a minimum of 4 TFBs in their promoter re-
gions in at least 2 of the 3 strains. This showed that the
same set of genes (except SP_0698) are commonly up-
regulated in the lungs and brain for WCH16 and WCH43
(see Additional file 10: Table S9). However, these
genes were not detected during lung infection by D39.
By contrast, only one gene (SP_1329), a putative N-
acetylneuraminate lyase, was up-regulated in WCH43
and D39 in the blood. These results are complementary to
data presented in Additional file 8: Table S7.Genes harboring higher numbers of regulatory elements
constitute a novel index of quality-based gene selection
We developed a new quality-based selection index based
on mining of the number of regulatory elements on the
promoter regions of up-regulated genes controlled by
the 7 highly activated TFs. Specifically, we hypothesized
that genes containing higher numbers of TFBs are likely
to play key roles in pneumococcal pathogenesis because
of their ability to host more TFs. Of the up-regulated
genes during infection of lungs and brain by WCH16
and WCH43, SP_0698 (ABC-2 type transport system
permease protein) was predicted to contain the highest
number of TFBs (13) in its promoter region (see Additional
file 11: Table S10). In the blood, WCH43 up-regulates
SP_2182 (a bacteriocin_IIc-type protein) with 18 TFBs
in its promoter region. However, in D39, SP_0124 and
SP_0125 (bacteriocin_IIc-type proteins), SP_0874 and
SP_1036 (hypothetical proteins), and SP_1608 (a DadA-
Figure 4 Competition experiments between wild type D39 (A),
WCH16 (B), WCH43 (C) and their codYind isogenic counterparts
in the nasopharynx, lungs, blood and brain (n = 16) 36 h post-i.n.
infection with equal numbers (approx. 2.5 × 106 CFU) each of
wild type and isogenic derivative. Datum points are the ratio of
codYind bacteria to wild type for each animal. The horizontal broken
line represents a 1:1 ratio. The horizontal solid line denotes the
geometric mean ratio for each comparison (NS = Not Significant;
*** P < 0.001; **** P < 0.0001; one sample t-test, two-tailed).
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respectively) were up-regulated.
GO analysis of up-regulated genes containing higher
number of TFBs in lungs vs nasopharynx suggests that
these genes are involved in key metabolic processes such
as NADPH activity, fatty acid biosynthetic process, sugar
phosphotransferase system, membrane development, NAD
binding, and proteolysis. These processes are important
during colonization of the nasopharynx and translocation
to lungs by S. pneumoniae. In the blood vs lungs compari-
sons, genes containing high number of TFBs enrich GO
processes of ion binding (magnesium ion binding/iron ion
binding), transporter activity, metabolic process, as well as
ion transmembrane transport. These processes are vital for
survival of S. pneumoniae in the blood, highlighting the
important roles of such up-regulated genes with high TFBs
in their promoter regions in the blood. GO analysis of
up-regulated genes with high TFBs in the brain vs blood
comparison were found to be involved in important pro-
cesses such as NADPH activity, sugar:hydrogen symporter
activity, glutamine biosynthetic process, fatty acid biosyn-
thetic process, sugar phosphotransferase activity, kinase
activity, carbohydrate transmembrane transport, ion trans-
membrane transport, and NAD binding. These processes
facilitate the translocation, survival and adaptation of
WCH16 and WCH43 in the brain.Domain activation profiles of different pneumococcal
strains during pathogenesis
We reasoned that the study of activated domains of
expressed proteins in addition to promoter activation
profiles could result in a better understanding of func-
tional genomics because of its use in vaccine design.
Therefore, we predicted the complete domain activa-
tion catalogue of WCH16, WCH43 and D39 during
infection of various host tissues. Accordingly, WCH16
(which is less virulent than WCH43 and D39) is predicted
to have the highest amount of its domain activation in the
lungs, with 74 predicted domains, compared to 31 for
D39 and 23 for WCH43 (Table 2 and Additional file 12:
Table S11). Our analysis also suggests that WCH16
has relatively low activation in the blood, with only
one predicted activated domain [(N6_N4_Mtase (DNA
Table 2 Number of activated protein domains by virulence
machinery of different S. pneumoniae strains during
movement from the nasopharynx→ lungs→ blood→ brain
Strain Lungs vs nasopharynx Blood vs lungs Brain vs blood
WCH16 74 1 105
WCH43 23 14 110
D39 31 470 0
Figure 5 Transcription factor-based regulatory network analysis of S. pneumoniae strains during infection. (A) Regulatory network
underlying transition of WCH16 from Nasopharynx to Lungs. (B) Regulatory network underlying transition of WCH16 from Lungs to Blood. (C) Regulatory
network underlying transition of WCH16 from Blood to Brain. (D) Regulatory network underlying transition of WCH43 from Nasopharynx to Lungs. (E)
Regulatory network underlying transition of WCH43 from Lungs to Blood. (F) Regulatory network underlying transition of WCH43 from Blood to Brain.
(G) Regulatory network underlying transition of D39 from Nasopharynx to Lungs. (H) Regulatory network underlying transition of D39 from Lungs
to Blood.
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dicted to activate 14 domains in the blood, while D39
is predicted to exhibit the most remarkable profile,
activating 470 possible domains in the blood. It is also
predicted that energy producing domains such as ATPase
family associated, ATP-synt_ab_N (ATP synthase alpha/
beta subunits) and ABC transporters are used by D39
to maintain fulminant bacteremia (Additional file 12:
Table S11).
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and WCH43 in the brain revealed that the number of
activated domains for both strains are essentially similar
(105 and 110, respectively; Table 2). The only slight differ-
ence is that in WCH43 more activated domains including
energy-producing (such as ATP-grasp), two-component
regulatory system, tRNA, ribosomal and PTS systems
domains were found.
Discussion
In this work, we have used a functional genomics-based
approach to provide a comprehensive prediction of TF
activation profiles and domain expression patterns of 3
different S. pneumoniae strains during pathogenesis. It
has been suggested that the TF and promoter activation
map of an organism can be obtained by comparison with
the fully annotated map of an ortholog [22-24] given the
fact that functional specificity of proteins is conserved
among orthologs [25]. Therefore, we exploited the avail-
able E. coli transcriptional regulation data to gain infor-
mation on the orthologous TF and promoter activation
map of 3 S. pneumoniae strains (WCH16, WCH43 and
D39) during pathogenesis. However, it has been argued
that such methods have shortcomings when applied to
distantly related organisms [38]. We attempted to address
this potential drawback by using an approach that predicts
the function of genes based on the similarity/difference in
the pattern of TFBs. The identified potential TFBs and
their organization modules provide another way to under-
stand gene expression and regulation during pathogenesis.
Taking into account these approaches, we present a strat-
egy for selection of novel antibacterial targets and vaccine
candidates.
In a recent investigation [21], we introduced the concept
of bacterial niche-specific virulence gene expression
during pathogenesis by qualitative comparisons of tran-
scriptomic data of one niche versus the previous niche.
In the present study, we carried out an in-depth analysis
of the TF-regulatory network that govern this transition
in order to shed light on the virulence factors that S.
pneumoniae employs to breach host tissue barriers. Our
analysis showed that 7 TFs (argR, codY, hup, rpoD, rr02,
scrR and smrC) were highly activated in all 3 strains
in vivo and were capable of binding to a large number
of up-regulated genes. We suggest that these TFs might
constitute the regulatory backbone that underpins
pneumococcal pathogenesis. We also found that these
TFs were used by D39 in blood and by WCH16 and
WCH43 during brain infection.
A close examination of activated TFs of the 3 strains
suggests that S. pneumoniae adapts to each host niche
during infection by increasing the number of TFs deployed
(and their TFBs). As a corollary, the number of activated
TFs is reduced if the bacteria are unable to adapt to aparticular niche (e.g. WCH16 in the blood). Not surpris-
ingly, rpoD was the most active TF for all 3 strains in all
niches, consistent with its role in promoting the attach-
ment of RNA polymerase to specific initiation sites during
transcription. The observed similarity between the pre-
dicted TF activation profiles and their clustering patterns
between distinct niches suggests that different S. pneu-
moniae strains might activate the same set of TFs and
regulatory elements at different sites of infection. This
is further supported by discriminant function analysis of
the TFs in various niches, which highlights differential
regulatory backgrounds of the 3 strains in the blood.
We also provide experimental evidence that validates the
predicted discriminant function for CodY between the 3
strains by showing distinct pathogenic profiles of their
otherwise isogenic codY induced derivatives in various
anatomical niches of mice. The results are consistent
with our in vivo microarray and real-time RT-PCR data
showing differential expression of CodY-regulated viru-
lence genes such as aliA, ilvH and piuA in various niches
of mice [13], and are also in agreement with results from
other workers [33]. Furthermore, the predicted domain
activation catalogues of these strains during pathogenesis
suggests that their functional domain profiles differed
mainly in the blood, with only one domain (DNA meth-
yltransferase) activated for WCH16, 14 for WCH43 and
470 domains for D39. These results are consistent with
gene ontology classifications for WCH16 and WCH43
[21,39], and in agreement with our published observa-
tions showing that these 3 strains display distinct patho-
genicity characteristics [21,31,39].
Our analyses also showed that some genes could poten-
tially be regulated by multiple TFs. For example, SP_1647
(a metallo-endopeptidase) was predicted to be regulated
by argR, hup, rpoD and rr02 in the lungs of D39-infected
mice. Notably, this gene has recently been characterized
to have a role in pneumococcal attachment and internal-
ization in host epithelial (A549) and endothelial (HUVEC)
cell lines [40]. We also developed a new quality-based
strategy for selection of genes important for pathogenesis,
based on mining of the number of TFBs in their promoter
regions. GO analysis of such genes allowed us to propose
that number of TFBs in the promoter regions of up-
regulated genes is an important and novel index for se-
lection of genes that play key roles at distinct stages of
pneumococcal pathogenesis. In this context, we found,
amongst other genes, a group of class IIc bacteriocins
that harbor the highest number of TFBs in WCH43
and D39 harvested from the blood. Bacteriocins have
been shown to be involved in fratricide in S. pneumoniae,
a phenomenon that favors natural competence and patho-
genesis in this organism [41,42]. Additionally, a putative
N-acetylneuraminate lyase (SP_1329) was up-regulated by
both WCH43 and D39 in blood, suggesting a need for this
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niche.
It has been suggested that regulation of pneumococcal
virulence proteins is very complex and multifactorial,
and likely involves overlapping regulatory mechanisms
[43]. We found that all the highly activated TFs argR,
codY, hup, rr02, scrR and smrC), except rpoD, clustered
together in all 3 strains. This is a significant finding,
implying redundancy in the regulatory roles of these
TFs during infection, as the functions of these TFs in
pathogenesis and regulation of virulence gene expression
have hitherto been studied in isolation [7,33,34,44-47]. In-
deed, this notion is exemplified by our recent work, which
showed that a defined mutation of smrC in a WCH43
background did not completely abrogate virulence [21]. In
the same context, we showed in Figure 4 that the same
groups of up-regulated genes are predicted to be co-
regulated by similar sets of TFs. These findings might
explain a fundamental problem associated with preven-
tion and control of pneumococcal disease, as it appears
that the task of identifying the principal targets of inter-
vention would be challenging. Therefore, a thorough ana-
lysis of the important regulatory pathways employed by S.
pneumoniae in different in vivo niches would likely im-
prove our knowledge of pneumococcal pathogenesis and
identify novel targets for intervention.
Conclusions
Our findings suggest a possible evolutionary strategy for
the pneumococcus in which the evolution occurs in
non-coding promoter regions of genes during infection.
Specifically, the pneumococcus changes the short bind-
ing sites in the promoter regions of genes instead of
alteration of coding sequences in a niche-specific manner
to generate more virulent strains. There are two important
caveats of this study. Firstly, we utilized the fully anno-
tated E. coli promoter listings to pull out the orthologous
TFs in S. pneumoniae, which might not represent the full
array of active promoters in the pneumococcus. Secondly,
the microarray slides used in this study cannot detect the
expression of unique WCH16-specific genes that are
absent in TIGR4 and R6 genomes represented on the
slides. Nevertheless, this study is the first such investi-
gation; it provides a framework towards a better under-
standing of the dynamics of pneumococcal pathogenesis,
and opens new avenues into similar investigations in other
pathogenic bacteria.
Methods
Bacterial strains and growth conditions
The pneumococcal strains used in this study were D39
(serotype 2; Sequence Type 595), clinical blood isolates
WCH43 (serotype 4; Sequence Type 205) and WCH16
(serotype 6A; Sequence Type 4966). Previous mouseintranasal challenge experiments in our laboratory with
these strains indicated that D39 causes fulminant bacter-
aemia; WCH43 demonstrates the “classical” disease pro-
gression from the nasopharynx to the lungs, followed by
dissemination to the blood and then to the brain, while
WCH16 demonstrates minimal lung and blood involve-
ment before translocation to the brain [31] Serotype-
specific capsule production was confirmed by Quellung
reaction, as described previously [48]. Opaque-phase vari-
ants of the strains, selected on Todd-Hewitt broth supple-
mented with 1% yeast extract (THY)-catalase plates [49],
were used in all animal experiments. Before infection, the
bacteria were grown statically at 37°C in serum broth (SB)
to A600 of 0.16 (equivalent to approx. 5 × 10
7 CFU/ml).
Microarray analysis of RNA extracted from different
mouse tissues during pathogenesis
For this investigation, we analyzed 72 h-microarray data
of in vivo-derived RNA samples obtained from our pre-
vious studies with WCH16 and WCH43 [12,13] as well
as that generated for D39 [12,13,31,50]. Our previous
studies have also established that after intranasal infection
of CD-1 mice, the number of pneumococci recovered
from various tissues peaked at 72 hr after which the mice
succumbed to infection quite rapidly [31]. Therefore, we
focused on this time point for further differential gene
expression analyses. This was carried out by a modified
two-color microarray analysis where the relative expres-
sion of each gene in one niche was calculated in compari-
son to expression in the previous niche when bacteria
moves from the nasopharynx to lungs to blood and then
to brain. Differential gene expression values with p < 0.05
were considered as statistically significant (one-sample
t-test). In the case of multiple comparisons, T- Hotelling
using Minitab 16 package (http://www.minitab.com) was
used to adjust p-values and decrease type I error. The goal
of this analysis was to unravel pneumococcal gene expres-
sion patterns in the nasopharynx, lungs, blood and brain
of mice.
Promoter extraction of up-regulated genes
In order to carry out a detailed characterization of the
pneumococcal TFs that are active in each host niche
during infection, a series of analyses were performed
(Figure 6). Firstly, pneumococcal genes that were signifi-
cantly up-regulated in each niche at 72 h were identified
by pairwise comparison of expression levels of each gene
in one niche versus the previous niche (e.g. lungs vs
nasopharynx, blood vs lungs, brain vs blood). Databases
containing full genomic sequences of S. pneumoniae
TIGR4 and D39, such as Microbesonline (http://www.
microbesonline.org/) [51,52] and KEGG (http://www.
genome.jp/kegg/), were used to find the genomic loca-
tion of up-regulated genes. Then, the potential promoter
Figure 6 Schematic representation of the step-by-step procedure for extraction of promoter regions up-regulated genes of S.
pneumoniae during infection for TF discovery, clustering, discriminant function analyses, promoter-based gene network interaction
and mutational studies.
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S. pneumoniae strains were extracted as follows. The
upstream region between each up-regulated gene (or
operon) and the next gene (or operon) was extracted
from KEGG, Microbesonline database, or Genome-Tools
Web Interface (http://genome-tools.sourceforge.net/cgi-bin/
genome-tools-web-interface.pl) [53]. The promoter analysis
covers the entire promoter region of each gene or operon.
Existence of a promoter and its −10 and −35 sites was
confirmed for up-regulated genes using BPROM algorithm
(http://linux1.softberry.com/berry.phtml?topic=bprom&-
group=programs&subgroup=gfindb). The algorithm pre-
dicts potential transcription start positions of bacterial
genes regulated by sigma70 promoters using linear discrim-
inant function. As the prediction tools for determining
TFBs are not as complete in S. pneumoniae, we used the
TFB prediction tool of E. coli to predict TFBs on the
extracted promoter regions for each gene by pattern
matching using the BPROM tool at the SoftBerry portal
(http://linux1.softberry.com/berry.phtml) [54]. TFs werepredicted for all extracted promoter sequences of up-
regulated genes in all niches of WCH16, WCH43, and
D39 using RegPrecise (http://regprecise.lbl.gov/RegPre-
cise/) [55] and BPROM web applications. The number of
regulatory elements (TFBs) in the promoter region of each
gene was recorded. In each niche, TFs with the highest
number of TFBs in the promoter regions of up-regulated
genes were determined for each strain. The number of
TFBs for each TF was also recorded. We chose 7 TFs with
at least 100 TFBs in their promoter regions as a cut-off for
further analysis.
Comparative analysis of TF activation in different niches
Based on promoter analysis of up-regulated genes, a map
of TF activation was estimated in different niches for the 3
strains. To obtain a clear understanding of similarities
and/or differences in TF activation, TFs were clustered
according to the number of TFBs on promoter regions
of up-regulated genes during infection by hierarchical
clustering analysis (HCA). This was achieved by count
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promoter regions of up-regulated genes in each niche
comparison) for all strains. When a particular TF does
not have a potential binding site on promoter regions of
up-regulated genes, a value of “0” was placed in the data.
For each strain, similarities/differences in different TF
activation patterns (in terms of potential binding to pro-
moter regions of up-regulated genes) were calculated by
average linkage method based on Euclidean distance
measure [56]. Dendograms were designed based on calcu-
lated similarity matrixes by Minitab 16 package (http://
www.minitab.com) to visualise differential binding patterns.
In addition, clustering of overall TF activation map in
all strains and niches was carried out as described
above. The hierarchical clustering analyses were validated
using c1Valid R Package [32], by internal and stability
cluster validation measures. Internal measures represent
the compactness, connectedness, and separation of the
cluster partitions by Connectivity, Silhouette Width and
Dunn Index, where lower Connectivity but higher Dunn
and Silhouette represent better scores. Stability measures
assess the results from the full clustering data based on
removing each column, one at a time. The Stability mea-
sures evaluated were: Average proportion of non-overlap
(APN), Average distance (AD), Average distance between
means (ADM) and Figure of merit (FOM); lower APN,
AD, ADM, and FOM represent better scores. We then
specified best threshold line to generate 2 clusters.
Discriminant function analysis
We used linear discriminant statistical analysis to deter-
mine the functions of TFs and used this information to
discriminate between the impact of a particular TF in each
niche between two groups (e.g. WCH16 vs WCH43,
WCH16 vs D39, WCH43 vs D39). This predictive algo-
rithm provides an accurate comparative index of TF
function, whereby TFs with relative higher coefficient
values (either positive or negative) have significant influ-
ence/impact in a particular niche between the two groups
being compared.
GO analysis of up-regulated genes with high number of
TFBs in their promoter regions
Up-regulated genes containing higher number of TFBs
during pneumococcal pathogenesis were subjected to
GO classification for their functional association cat-
egories with respect to molecular function and biological
process, using our recently developed bacterial GO web
application [39,57].
TF–based network construction of pneumococcal
pathogenesis
A database was made based on the results of promoter
analysis linking the genes to TFs. TF-based regulatorynetworks were designed in different niches for each
strain based on the developed database. The database
relationships were visualised using PathwayStudio 9
(Elsevier, USA). The database is available upon request.
Extraction of domain profile of up-regulated genes
Protein sequences of up-regulated genes of WCH16,
WCH43, and D39 were extracted from PIR (Protein In-
formation Resource) databases (http://pir.georgetown.
edu/cgi-bin/batch.pl). Then, domains of each protein
sequence were extracted from pfam database (http://
pfam.sanger.ac.uk/) and CLC Genomics Workbench 6
(http://www.clcbio.com/). For domain prediction, E-value =
0.0000001was used to extract the significant domains.
Construction of mutants and assessment of bacterial growth
S. pneumoniae derivatives with marked mutations in
codY were constructed in the 3 strains. Mutants were
constructed by overlap extension PCR [58,59] and validated
by PCR and sequencing to be in-frame deletion mutation
replacements. All PCR procedures were performed with
the Phusion High Fidelity Kit (FINNZYMES). The primer
pairs used for construction and validation of the mutants
are listed in Additional file 13: Table S12. A recombinant
plasmid over-expressing codY was constructed by driving
its expression from ami promoter using pAL2 plasmid
[60] in which the luxABCDE cassette had been deleted
(pAL2ΔluxABCDE). The recombinant construct was
transformed into the 3 strains, generating D39[codY]ind,
WCH16[codY]ind, and D39[codY]ind, respectively. Induc-
tion of codY in these strains was confirmed by real-time
RT-PCR analysis.
In vitro competition experiments were performed as
described previously [21]. In this assay, mutant (or
codYind) and wild-type bacteria were grown to A600 in
SB and then mixed at an input ratio of 1:1 in SB. At 1.5
and 3 h post incubation, an aliquot of each sample was
serially diluted in SB and plated on blood agar and
blood agar with a selective antibiotic to determine the
ratio of mutant (or codYind) to wild-type bacteria. Each
competition experiment was repeated at least twice.
Competitive indices were calculated as the ratio (±SEM)
of mutant (or codYind) to wild-type bacteria recovered at
each time point adjusted by the input ratio.
Mixed infection experiments
Competition experiments were carried out essentially as
described previously [12]. Briefly, 8 mice were anesthe-
tized by intraperitoneal injection of pentobarbital sodium
(Nembutal; Rhone-Merieux) at a dose of 66 mg per g of
body weight and separately challenged i.n. with 50 μl sus-
pension containing approx. 2.5 × 106 CFU of either wild-
type or the isogenic codYind strain. At 36 h post-challenge,
mice from each separate infection experiment were
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ynx, lungs blood and brain, by plating on blood agar and
blood agar with a selective antibiotic to determine the ra-
tio of the codYind strain to wild-type bacteria. Each compe-
tition experiment was repeated at least twice. Competitive
indices were calculated as the ratio (±SEM) of codYind
strain to wild-type bacteria recovered in each niche ad-
justed by the input ratio.Ethical considerations
Outbred 5- to 6-week-old female CD1 (Swiss) mice were
used in all experiments. The Animal Ethics Committee of
The University of Adelaide approved all animal experi-
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also ArrayExpress (accession number E-BUGS-130, and
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